You are here

Companies

Parc Tecnològic Vallès
22.02.2017

The product, Zelium, is a therapeutic alternative for treating a serious complication in diabetic patients

Transplant Biomedicals
23.01.2017

Caixa Capital Risc and Kereon Partners have invested in this spin-off created through technology transfer from IDIBAPS-Hospital Clínic de Barcelona

Bionure Estamosaesto
17.01.2017

The biotech firm has opened a crowdequity round of funding on the Capital Cell platform and has created a campaign on social media

Grifols
16.01.2017

The agreement also includes a purchase option on the remaining 51%, which the Catalan multinational corporation may exercise in 2022

Iproteos
16.01.2017

The firm has published a study with the University of the Basque Country and IRB Barcelona and is beginning the preclinical regulatory phase for the candidate

Aromics
12.01.2017

The biotech firm has launched a crowd-funding campaign through Capital Cell to complete the preclinical phase and begin trials in humans

Mosaic Biomedicals
13.01.2017

The deal will accelerate development of a new antibody to fight cancer

Doctoralia
07.06.2016

The two companies will be present in 25 countries and together will have the largest database of healthcare professionals in the world

Shanghai
21.12.2016

ACCIÓ is organising a mission to Shanghai and Hong Kong for businesses and institutions in collaboration with Biocat, Fenin and Health Tech Cluster

Marc Martinell
16.12.2016

The company is developing MIN-102 to treat X-linked Adrenoleukodystrophy, a rare disease of the central nervous system with no treatment